These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids. White CM J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597 [TBL] [Abstract][Full Text] [Related]
9. Cannabinoid hyperemesis. Sannarangappa V; Tan C Intern Med J; 2009 Nov; 39(11):777-8. PubMed ID: 19912406 [No Abstract] [Full Text] [Related]
16. Synthetic cannabinoid hyperemesis resulting in rhabdomyolysis and acute renal failure. Argamany JR; Reveles KR; Duhon B Am J Emerg Med; 2016 Apr; 34(4):765.e1-2. PubMed ID: 26422191 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoid Hyperemesis Syndrome: Descriptive Overview of an Under-Recognized Diagnosis. Braver O; Leibman Y Isr Med Assoc J; 2015 May; 17(5):324-5. PubMed ID: 26137664 [No Abstract] [Full Text] [Related]
18. Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study. Wilson W; Mathew R; Turkington T; Hawk T; Coleman RE; Provenzale J J Addict Dis; 2000; 19(1):1-22. PubMed ID: 10772599 [TBL] [Abstract][Full Text] [Related]
19. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure. Gudsoorkar VS; Perez JA Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029 [TBL] [Abstract][Full Text] [Related]
20. A public health approach to increased synthetic cannabinoid-related morbidity among New York City residents, 2014-2015. Nolan ML; Allen B; Kunins HV; Paone D Int J Drug Policy; 2016 Aug; 34():101-3. PubMed ID: 27453146 [No Abstract] [Full Text] [Related] [Next] [New Search]